News & Announcements

Making Connections 2022 Consultation

09 December 2022

Everyone living in Greater Cambridge can have their say on the Making Connections proposals - read on to see the new interactive bus map, to see how your journey to work could be impacted by more frequent bus services.

Read More

RxCelerate acquires Methuselah Health and launches ProQuant™ world-beating proteomics service

23 November 2022

RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery company Methuselah Health UK Ltd for an undisclosed sum.

Read More

Babraham Research Campus Ltd appoints Kathryn Chapman as Director of Science & Entrepreneurship

21 November 2022

Babraham Research Campus Ltd is delighted to announce the appointment of Dr Kathryn Chapman to the newly created role of Director, Science & Entrepreneurship.

Read More

My STEMM Future is recruiting for guest speakers

18 November 2022

My STEMM Future is a collaboration between Wellcome Connecting Science, scientists at the Wellcome Genome Campus and The Youth STEMM Award.

Read More

The BBSRC ICURe EXPLORE Programme

11 November 2022

Up to £25k of funding and training is available for researchers, PhD students and technicians. Find out more.

Read More

Applications for PULSE 2023 are now open

09 November 2022

Aimed at aspiring entrepreneurs and first-time CEO's looking for advanced practical advice, support and feedback.

Read More

Campus Christmas Closure dates

07 November 2022

Find out when the Campus closes for Christmas and what services will be available.

Read More

Adrestia appoints Head of Chemistry and initiates multi-target partnership with Proteros to discover first-in-class drugs for intractable genetic diseases

03 November 2022

Adrestia Therapeutics announced the appointment of Dr James Osborne as Head of Chemistry and the initiation of a multi-target partnership with Proteros biostructures GmbH (Munich, Germany).

Read More

Duo join ethics and sustainability board as bit.bio adds two new cell products to ‘menu’

02 November 2022

Two new members have been welcomed to bit.bio’s independent ethics and sustainability board to further support the company’s commitment to being a purpose-led, ethical organisation.

Read More

Babraham Research Campus receives funding for barrier-busting PhD programme

31 October 2022

Babraham Research Campus Ltd and the Babraham Institute have secured funding for fifteen PhD studentships from UKRI-BBSRC as part of a Collaborative Training Partnership (CTP).

Read More

Signatures restaurant will reopen on 24 Oct

21 October 2022

Located in the Bennet building, Signatures Cafe will reopen as a self-service facility.

Read More

Do you love singing on your own or with others?

19 October 2022

Babraham Research Campus along with Cambridge Biomedical Campus and Granta Park are coming together to form a group of like-minded people who enjoy a good singalong.

Read More

Royal Mail Strikes

19 October 2022

Please be aware of the forthcoming Royal Mail Strikes. Click here for dates.

Read More

Babraham Institute mentoring scheme

12 October 2022

BI are looking for mentors from campus companies to mentor researchers and PhD students.

Read More

Lonza's Road to First in Human Webinar Series

10 October 2022

Lonza is sharing a series of five educational, free webinars entitled “ Expert Series: Road to First in Human” designed to help early-stage biotechs de-risk development projects, accelerate approval, maximise molecule values and simplify development.

Read More

BioMed Realty partners with Babraham Research Campus Limited to expand the Campus and its ecosystem

03 October 2022

BioMed Realty is expanding its footprint at the Babraham Research Campus following the formation of a joint venture with Babraham Research Campus to deliver a 40,000 square foot purpose-built building with new fitted laboratory space.

Read More

Campus Closure: Mon 19th Sept

15 September 2022

As a mark of respect, Babraham Research Campus Limited will be closed on Monday 19th September, the day of the Queen’s funeral.

Read More

WASTE AUDITOR VISIT 8th Sept

07 September 2022

Matt Antrobus our Head of Estates, will be walking around the Campus with a Waste Auditor tomorrow. They will be visiting buildings and tenanted areas, selected at random, and potentially looking to ask some questions of tenants about what clinical/hazardous wastes are being produced and how waste is segregated.

Read More

Springer Nature Exclusive Discount

05 September 2022

Babraham Research Campus tenants* can now claim 10% discount off ANY of Nature’s 90+ other journals.

Read More

Notice of Build Works on Campus

01 August 2022

Further to Planning Permission granted at the end of last year, we are now able to commence work on B960; the new building located directly South of B940 and B950.

Read More

Deck chairs for you to enjoy

28 July 2022

Feel free to enjoy the new deck chairs, located on the back lawn and beside Minerva

Read More

Call for funding proposals to the Babraham Research Campus Collaboration Fund

20 July 2022

In 2022/23, this UKRI-BBSRC fund awarded to Babraham Research Campus Ltd, will support five collaborative research projects each worth up to £30,000.

Read More

Logs, kindling and charcoal for sale

20 July 2022

The Estates team have seasoned firewood available for sale, produced from timber sourced on-site, which arises from tree surgery works around the campus, as well as from our Woodland Conservation Programme.

Read More

Bike Pumps

20 July 2022

Bike pumps are available at B910 bike shed

Read More

Investor conference returns in new hybrid format

30 June 2022

We were delighted to welcome over 70 investors back to the Campus for the Investor Conference, which was also streamed online to over 50 viewers.

Read More

Bicycle Therapeutics in-conversation with JLL

30 June 2022

Hear how the demand profile of life science companies changes as their businesses mature, and how real estate decisions are now primarily based on the desires and needs of employees in the post-pandemic world.

Read More

Female leaders join bit.bio with COO ‘proud of team we’re building’

24 June 2022

Kathryn Corzo took up the role of chief operating officer (COO) at synthetic biology company bit.bio in November.

Read More

Transine Therapeutics poised for growth with new CSO hire and tripling of lab space

23 June 2022

Transine Therapeutics today announced the appointment of Andy Billinton as Chief Scientific Officer as it triples its facility footprint at The Babraham Research Campus.

Read More

Dr Simon Cook appointed Institute Director

09 June 2022

The Board of Trustees is delighted to announce that Dr Simon Cook has been appointed as the Institute’s Director.

Read More

Five Cambridge companies in inaugural Growth Index study

01 June 2022

Five Cambridge companies have made it to the inaugural Growth Index, a ranking of the fastest growing companies in the UK based on a rigorous financial analysis of the compound annual growth of 32,000 companies.

Read More

Babraham Institute launches a new digital look

23 May 2022

There’s a fresh new look to the Babraham Institute’s website, click here to see the lighter, brighter and improved digital experience.

Read More

NVIDIA brings Alchemab into the Cambridge-1 supercomputer project

19 May 2022

Cambridge biotech pioneer Alchemab Therapeutics has been chosen by US tech giant NVIDIA to harness the power of  the UK’s most powerful supercomputer, Cambridge-1. 

Read More

15% off Cambs Cuisine

17 May 2022

Discount at CambsCuisine for all Babraham Research Campus staff

Read More

Benefits of plants in the office

17 May 2022

Why are plants so good for us in our workspace? The Good Plant Company can tell us why, including how you can work with them to improve your office.

Read More

Ongoing works to improve the River

17 May 2022

Major work has just been completed the river to improve habitat for wildlife, provide a better view of the river for walkers and improve the ability of the river to cope with floods and droughts.

Read More

Cambridge Independent Science & Technology Awards

12 May 2022

Delighted to see so many companies and Accelerate at Babraham alumni being recognised at the recent awards ceremony.

Read More

Sphere Fluidics strengthens commercial team with three new senior hires

12 May 2022

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed three new hires to its commercial team.

Read More

Cambridge company’s disease model sheds new light on Huntington’s

11 May 2022

A new disease model – one of the first of its kind to be made commercially available – is being hailed as a key pathfinder in reflecting the genetics of Huntington’s disease.

Read More

Abzena shows sixth sense with California expansion

05 May 2022

Life science power player Abzena, whose global headquarters is at Babraham Research Campus in Cambridge, has added a sixth site to its global operations network with expansion in California.

Read More

BBSRC Business and Academia Prosperity Partnership

05 May 2022

The BBSRC have released an £11m grant fund to support established research partnerships between business and academic institutions.

Read More

Assessing Life Sciences Skill Requirements in the Oxford Cambridge Arc

03 May 2022

Whitecap Consulting has been appointed by The Open University to research and analyse workforce skills and associated requirements in the growing Life Sciences sector in the Oxford-Cambridge Arc to 2030.

Read More

Nature Subscription: 45% discount for the world famous journal

28 April 2022

Exclusive discount offer for Babraham Research Campus tenants to the world-famous scientific journal Nature.

Read More

Supporting Cambridge's Life Sciences Ecosystem: Q&A With James Seppala and Tim Schoen

28 April 2022

James Seppala and Tim Schoen discuss BioMed Realty’s footprint in the UK and the opportunity in the life sciences real estate market in the years ahead.

Read More

Cambridge irons out the wrinkles in anti-ageing science arena

25 April 2022

Cambridge is playing a lead role in developing technology designed to rejuvenate skin cells and arrest the march of age-related diseases.

Read More

How Adrestia Therapeutics is pioneering synthetic rescue - an interview with Prof Steve Jackson and CEO Robert Johnson

19 April 2022

A new approach to tackling genetic diseases could unlock treatments to some of the most intractable conditions, it is hoped.

Read More

Old skins cells reprogrammed to regain youthful function. Findings could lead to targeted approach for treating ageing

08 April 2022

Research from the Babraham Institute has developed a method to ‘time jump’ human skin cells by 30 years, turning back the ageing clock for cells without losing their specialised function.

Read More

From ‘a metaphorical slap around the face’ to ‘life-saving’ - how life science start-ups view Accelerate@Babraham

04 April 2022

The latest cohort of five life science start-ups to complete the 2021/22 cycle of Accelerate at Babraham may have had the added pressure of a pandemic throughout the five-month programme but all made great strides to develop their business propositions, which in turn promises to change patient outcomes.

Read More

Alchemab selected to access NVIDIA Cambridge-1 supercomputer to advance machine learning enabled antibody discovery

24 March 2022

Alchemab Therapeutics has been selected by NVIDIA to harness the power of the UK’s most powerful supercomputer, Cambridge-1.

Read More

Volunteers help plant community forest garden with edible plants at Babraham Research Campus

03 March 2022

A community forest garden full of edible plants is being created within the estate of Babraham Research Campus, thanks to council funding and the work of volunteers.

Read More

Accelerate@Babraham alumni, Shift Bioscience is hiring!

21 February 2022

The longevity biotech company using machine learning to develop therapeutics for safe cellular reprogramming has three open positions.

Read More

‘Globally important’ Babraham Research Campus given go ahead to expand

25 January 2022

The Babraham Research Campus – one of the UK’s leading locations supporting early-stage bioscience enterprise – has been given the go ahead to expand, to ensure the UK life science research and development sector can continue to deliver world-changing health solutions.

Read More

We must rethink PhDs to smash barriers and ensure bioscience success

21 January 2022

Redesigning PhD training will help develop commercially savvy researchers, address skills gaps in UK bioscience and bolster innovation, say Simon Cook and Derek Jones.

Read More

There is still time to enter the CambridgeshireLive Business Excellence Awards 2022

19 January 2022

Entries for the awards close on Friday 21 January!

Read More

Sphere Fluidics closes $40m investment round to fund international expansion of Cyto-Mine technology

04 November 2021

Sphere Fluidics has closed a $40million (around £30m) investment round to expand its international sales activities.

Read More

Enterprising Minds: Man on a Mission

29 October 2021

An interview with Steve Jackson, Founder and former CSO of Mission Therapeutics; Founder, CSO and Interim CEO of Adrestia Therapeutics.

Read More

Bicycle Therapeutics wheels in $201.3m growth capital

25 October 2021

Transatlantic biotech game-changer Bicycle Therapeutics is wowing NASDAQ with its 12-month performance and fundraising magic.

Read More

TRx Biosciences launched with blessing of Yusuf Hamied and Babraham Research Campus

15 October 2021

Robin Bannister, TRx Biosciences’ CEO, said Cipla chairman Dr Yusuf Hamied is “a super investor to have on board” at the launch of TRx Biosciences on Babraham Research Campus yesterday.

Read More

Mission Therapeutics Awarded Follow-On Therapeutic Pipeline Program Grant from The Michael J. Fox Foundation

14 October 2021

Mission Therapeutics announced today that it has been awarded a Therapeutic Pipeline Program grant of approximately 0.5M USD from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

Read More

Lucy Cavendish College launches innovative and unique Life Sciences Community

24 September 2021

The supportive and inclusive collaboration will provide new opportunities for STEMM students and improve employment prospects.

Read More

CC Bio aims to improve health of millions of women and cystic fibrosis patients with microbiome editing technology

24 September 2021

The lives of millions of women around the world could be improved by extraordinary microbiome editing technology pioneered by synthetic biology start-up CC Bio.

Read More

Huntington’s disease progression stopped in cell study by University of Cambridge and UCL researchers

08 September 2021

Exciting progress has been made in the lab in the fight against Huntington’s disease. Scientists at the University of Cambridge and UCL have identified a mechanism that stops its progression in cells.

Read More

Cambridge Judge Business School are launching a new programme focusing on sustainability

26 August 2021

Would you like to be a part of the first ever Venture Creation: Sustainability cohort. Participation in the programme will help delegates develop their capacity for future innovation in addition to an entrepreneurial mindset that will support them throughout their career choices.

Read More

Ignite Founders’ Challenge - backing the next generation of early-stage entrepreneurs

26 August 2021

Judge Business School are delighted to announce Ignite Founder's Challenge starting in the Autumn term - is now open for applications. A specially designed four-week online programme for early-stage startups that consists of workshops and coaching sessions to transform your idea into a reality.

Read More

New technologies and early-stage ideas are needed for EnterpriseTECH student projects

26 August 2021

Judge Business School have an exciting opportunity for inventors. Would you like to find out if your early-stage research results or new or novel technology has commercial potential? Applications are open to submit project proposals for student teams to work on. The deadline for submissions is 6th September 2021.

Read More

Enabling Interaction

15 July 2021

Our CEO, Derek Jones speaks to UKSPA’s BreakThrough magazine about the history, evolution and achievements of the life sciences’ community at the Babraham Research Campus.

Read More

Over £200m invested in Babraham Campus companies in last year – but what lies ahead?

15 July 2021

The Babraham Investor Conference 2021 (BIC), an event for investors focusing on early-stage and scale-up life science and med-tech companies, moved online for the first time in its 15-year history.

Read More

Bicycle Therapeutics Enters Exclusive License and Collaboration Agreement with Ionis

14 July 2021

Bicycle Therapeutics today announced that Ionis Pharmaceuticals has exercised its option and entered into an exclusive worldwide license and collaboration agreement.

Read More

Adrestia Therapeutics in overdrive as it hires from new Cambridge HQ

14 July 2021

Cambridge life science business Adrestia Therapeutics is scaling fast as it accelerates its mission to rebalance disease and restore health.

Read More

New breast cancer drug could be ready within five years

14 July 2021

The treatment has been created by scientists at Cancer Research UK and Artios, a spin-out it set up in Cambridge to develop the drug which has received £90 million of funding.

Read More

The 25 Best Biotech Incubators Hatching Startup Stars in Europe

06 April 2021

Incubators can give biotech startups the boost they need to get off the ground. Accelerate@Babraham has made Labiotech's top 25 biotech incubators across Europe supporting the next generation of life science startups.

Read More